Susquehanna International Group
NUVB icon

Susquehanna International Group’s Nuvation Bio NUVB Stock Holding History

Susquehanna International Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$716K Sell
166,900
-576,100
-78% -$3.21M ﹤0.01% 8757
2025
Q4 		$6.66M Buy
743,000
+728,900
+5,170% +$4.52M ﹤0.01% 3601
2025
Q3 		$52.2K Sell
14,100
-1,198,500
-99% -$3.27M ﹤0.01% 11846
2025
Q2 		$2.36M Buy
+1,212,600
New +$2.53M ﹤0.01% 5435
2023
Q3 		– Sell
-16,100
Closed -$29K – 12656
2023
Q2 		$29K Buy
+16,100
New +$27.4K ﹤0.01% 11527

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's NUVB Position: Q1 2026 in Review

Susquehanna International Group increased its Nuvation Bio (NUVB) stake by 805% in Q1 2026, buying an estimated $712K and bringing the position to 143,613 shares worth $616K. The position accounts for ﹤0.01% of the portfolio, ranked #9119.

Susquehanna International Group first reported a position in NUVB in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.03M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Susquehanna International Group held 143,613 shares of Nuvation Bio worth $616K as of Q1 2026.
  • Susquehanna International Group bought 127,751 Nuvation Bio shares in Q1 2026, an estimated $712K.
  • Nuvation Bio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9119 holding.
  • Susquehanna International Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 19 quarters since.
  • Susquehanna International Group's Nuvation Bio position peaked at $3.03M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.